Form 4 for MRK Merck & Co.
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-02 · accession 0001127602-24-003099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-02 | 2024-02-02 | MRK | MIZELL STEVEN | EVP, Chief HR Off | M - OptEx | $73.65 | +33.0K | 74.3K | +80% | +$2.43M |
| D | 2024-02-02 | 2024-02-02 | MRK | MIZELL STEVEN | EVP, Chief HR Off | S - Sale+OE | $126.65 | -50.7K | 23.6K | -68% | -$6.42M |
| DM | 2024-02-02 | 2024-02-02 | MRK | MIZELL STEVEN | EVP, Chief HR Off | M - OptEx | $0.00 | -33.0K | 22.1K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | M | A | 824 | $70.71 | 42,143.15 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 50,694 | $126.65 | 23,619.15 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-02-02 | M | A | 32,170 | $73.73 | 74,313.15 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-02-02 | M | D | 824 | $0.00 | 0 | D | $70.71 · 2019-10-30 to 2028-10-29 | 824 Common Stock | (F2) The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-02-02 | M | D | 32,170 | $0.00 | 22,088 | D | $73.73 · 2022-05-04 to 2031-05-03 | 32,170 Common Stock | (F3) The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |